Your browser doesn't support javascript.
loading
Allergic sensitization impairs lung resident memory CD8 T-cell response and virus clearance.
Agrawal, Komal; Ong, Li Ching; Monkley, Susan; Thörn, Kristofer; Israelsson, Elisabeth; Baturcam, Engin; Rist, Cassie; Schön, Karin; Blake, Sophia; Magnusson, Björn; Cartwright, James; Mitra, Suman; Ravi, Abilash; Zounemat-Kermani, Nazanin; Krishnaswamy, Jayendra Kumar; Lycke, Nils Y; Gehrmann, Ulf; Mattsson, Johan.
Afiliação
  • Agrawal K; Translational Science & Experimental Medicine, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Ong LC; Department of Microbiology and Immunology, Gothenburg University, Gothenburg, Sweden.
  • Monkley S; Translational Science & Experimental Medicine, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Thörn K; Translational Science & Experimental Medicine, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Israelsson E; Translational Science & Experimental Medicine, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Baturcam E; Early Clinical Research, R&I, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Rist C; Translational Science & Experimental Medicine, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Schön K; Department of Microbiology and Immunology, Gothenburg University, Gothenburg, Sweden.
  • Blake S; Translational Science & Experimental Medicine, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Magnusson B; Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden.
  • Cartwright J; Respiratory & Immunology (IA) Safety, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Cambridge, United Kingdom.
  • Mitra S; Inserm UMR1277 CNRS UMR9020 - CANTHER, Institut pour la Recherche sur le Cancer de Lille, Lille, France.
  • Ravi A; the Department of Respiratory Medicine, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Zounemat-Kermani N; the Data Science Institute, Imperial College London, London, United Kingdom.
  • Krishnaswamy JK; Translational Science & Experimental Medicine, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Lycke NY; Department of Microbiology and Immunology, Gothenburg University, Gothenburg, Sweden.
  • Gehrmann U; Translational Science & Experimental Medicine, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Mattsson J; Translational Science & Experimental Medicine, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden. Electronic address: Johan.mattsson@astrazeneca.com.
J Allergy Clin Immunol ; 150(6): 1415-1426.e9, 2022 12.
Article em En | MEDLINE | ID: mdl-35917932
ABSTRACT

BACKGROUND:

Patients with asthma often suffer from frequent respiratory viral infections and reduced virus clearance. Lung resident memory T cells provide rapid protection against viral reinfections.

OBJECTIVE:

Because the development of resident memory T cells relies on the lung microenvironment, we investigated the impact of allergen sensitization on the development of virus-specific lung resident memory T cells and viral clearance.

METHODS:

Mice were sensitized with house dust mite extract followed by priming with X47 and a subsequent secondary influenza infection. Antiviral memory T-cell response and protection to viral infection was assessed before and after secondary influenza infection, respectively. Gene set variation analysis was performed on data sets from the U-BIOPRED asthma cohort using an IFN-γ-induced epithelial cell signature and a tissue resident memory T-cell signature.

RESULTS:

Viral loads were higher in lungs of sensitized compared with nonsensitized mice after secondary infection, indicating reduced virus clearance. X47 priming induced fewer antiviral lung resident memory CD8 T cells and resulted in lower pulmonary IFN-γ levels in the lungs of sensitized as compared with nonsensitized mice. Using data from the U-BIOPRED cohort, we found that patients with enrichment of epithelial IFN-γ-induced genes in nasal brushings and bronchial biopsies were also enriched in resident memory T-cell-associated genes, had more epithelial CD8 T cells, and reported significantly fewer exacerbations.

CONCLUSIONS:

The allergen-sensitized lung microenvironment interferes with the formation of antiviral resident memory CD8 T cells in lungs and virus clearance. Defective antiviral memory response might contribute to increased susceptibility of patients with asthma to viral exacerbations.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Influenza Humana / Células T de Memória Limite: Animals / Humans Idioma: En Revista: J Allergy Clin Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suécia

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Influenza Humana / Células T de Memória Limite: Animals / Humans Idioma: En Revista: J Allergy Clin Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suécia